Comparing the life concerns of prescription opioid and heroin users

Journal of Substance Abuse Treatment

Volumn 48, Issue 1, 2015, Pages 43-48

  Stein, Michael D ^a,b   Anderson, Bradley J ^a   Thurmond, Portia ^a   Bailey, Genie L ^b,c  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c Stanley Street Treatment and Resources Inc ^*  (United States)

Author keywords

Detoxification; Health concerns; Heroin; Opioids; Self reported health

Indexed keywords

DIAMORPHINE; OPIATE; PRESCRIPTION DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNICITY; FEMALE; HEALTH INSURANCE; HEROIN DEPENDENCE; HOMELESSNESS; HUMAN; LENGTH OF STAY; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MONEY; OPIATE ADDICTION; PATIENT WORRY; PRESCRIPTION; PRIORITY JOURNAL; RACE; SEX DIFFERENCE; SMOKING; SUMMATED RATING SCALE; ATTITUDE TO HEALTH; COMPARATIVE STUDY; DRUG MISUSE; PSYCHOLOGY;

ADULT; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEROIN DEPENDENCE; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE;

EID: 84922765881     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2014.07.001     Document Type: Article

References (41)

1. Adler N.E., Rehkopf D.H. U.S. disparities in health: Descriptions, causes, and mechanisms. Annual Review of Public Health 2008, 29:235-252. 10.1146/annurev.publhealth.29.020907.090852.
2. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence 2004, 73(2):199-207. (doi: S0376871603002904).
3. Carey M.P., Braaten L.S., Jaworski B.C., Durant L.E., Forsyth A.D. HIV and AIDS relative to other health, social, and relationship concerns among low-income urban women: A brief report. Journal of Women's Health & Gender-Based Medicine 1999, 8(5):657-661.
4. Carey M.P., Senn T.E. Health and life concerns among patients attending a publicly funded sexually transmitted infection clinic. Journal of Public Health Management and Practice 2013, 19(1):E30-E34. 10.1097/PHH.0b013e31822d4bd5.
5. Carrier E., McNeely J., Lobach I., Tay S., Gourevitch M.N., Raven M.C. Factors associated with frequent utilization of crisis substance use detoxification services. Journal of Addictive Diseases 2011, 30(2):116-122. (936254277 [pii]). 10.1080/10550887.2011.554776.
6. Center for Substance Abuse Treatment TIP 19: Detoxification from alcohol and other drugs: Treatment improvement protocol (TIP) Series 19; DHHS Publication No. (SMA) 95-3046 1995, Substance Abuse and Mental Health Services Administration, Rockville (MD).
7. Centers for Disease Control and Prevention State-specific prevalence of cigarette smoking among adults and quitting among persons aged 18-35years-United States, 2006. MMWR. Morbidity and Mortality Weekly Report 2007, 56(38):993-996.
8. Clarke J.G., Stein M.D., McGarry K.A., Gogineni A. Interest in smoking cessation among injection drug users. The American Journal on Addictions 2001, 10(2):159-166.
9. Gallo L.C., Bogart L.M., Vranceanu A.M., Matthews K.A. Socioeconomic status, resources, psychological experiences, and emotional responses: A test of the reserve capacity model. Journal of Personality and Social Psychology 2005, 88(2):386-399.
10. Grella C.E., Lovinger K. Gender differences in physical and mental health outcomes among an aging cohort of individuals with a history of heroin dependence. Addictive Behaviors 2012, 37(3):306-312. 10.1016/j.addbeh.2011.11.028.
11. Hser Y.I., Hoffman V., Grella C.E., Anglin M.D. A 33-year follow-up of narcotics addicts. [Research Support, U.S. Gov't, P.H.S.]. Archives of General Psychiatry 2001, 58(5):503-508. (doi: yoa20042 [pii]).
12. Hser Y.I., McCarthy W.J., Anglin M.D. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. Preventive Medicine 1994, 23(1):61-69. 10.1006/pmed.1994.1009.
13. Hubley A.M., Palepu A. Injection Drug User Quality of Life Scale (IDUQOL): Findings from a content validation study. Health and Quality of Life Outcomes 2007, 5:46-58. 10.1186/1477-7525-5-46.
14. Hurt R.D., Offord K.P., Croghan I.T., Gomez-Dahl L., Kottke T.E., Morse R.M., et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA 1996, 275(14):1097-1103.
15. Ickovics J.R. "Bundling" HIV prevention: Integrating services to promote synergistic gain. Preventive Medicine 2008, 46(3):222-225. 10.1016/j.ypmed.2007.09.006.
16. Kandel D.B., Huang F.Y., Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug and Alcohol Dependence 2001, 64(2):233-241. (doi: S0376-8716(01)00126-0 [pii]).
17. Kobau R., Safran M.A., Zack M.M., Moriarty D.G., Chapman D. Sad, blue, or depressed days, health behaviors and health-related quality of life, Behavioral Risk Factor Surveillance System, 1995-2000. Health and Quality of Life Outcomes 2004, 2:40. 10.1186/1477-7525-2-40.
18. Maisel N.C., Karney B.R. Socioeconomic status moderates associations among stressful events, mental health, and relationship satisfaction. Journal of Family Psychology 2012, 26(4):654-660. 10.1037/a0028901.
19. Mark T.L., Dilonardo J.D., Chalk M., Coffey R.M. Trends in inpatient detoxification services, 1992-1997. Journal of Substance Abuse Treatment 2002, 23(4):253-260. (doi: S0740547202002714 [pii]).
20. Mark T.L., Woody G.E., Juday T., Kleber H.D. The economic costs of heroin addiction in the United States. [Research Support, Non-U.S. Gov't]. Drug and Alcohol Dependence 2001, 61(2):195-206.
21. Masson C.L., Sorensen J.L., Batki S.L., Okin R., Delucchi K.L., Perlman D.C. Medical service use and financial charges among opioid users at a public hospital. Drug and Alcohol Dependence 2002, 66(1):45-50. (doi: S037687160100182X [pii]).
22. McEwen B.S., Seeman T. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Annals of the New York Academy of Sciences 1999, 896:30-47.
23. Moitra E., Anderson B.J., Stein M.D. Perceived stress and substance use in methadone-maintained smokers. Drug and Alcohol Dependence 2013, 133(2):785-788. 10.1016/j.drugalcdep.2013.08.010.
24. Moore B.A., Fiellin D.A., Barry D.T., Sullivan L.E., Chawarski M.C., O'Connor P.G., et al. Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine 2007, 22(4):527-530. 10.1007/s11606-007-0129-0.
25. Muthen L., Muthen B. MPlus User's Guide 2007, Muthen & Muthen, Los Angeles, CA. 5th ed.
26. Nahvi S., Richter K., Li X., Modali L., Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addictive Behaviors 2006, 31(11):2127-2134. 10.1016/j.addbeh.2006.01.006.
27. Nielsen S., Hillhouse M., Thomas C., Hasson A., Ling W. A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. Journal of Addiction Medicine 2013, 7(1):33-38. 10.1097/ADM.0b013e318277e92e.
28. Okoli C.T., Khara M., Procyshyn R.M., Johnson J.L., Barr A.M., Greaves L. Smoking cessation interventions among individuals in methadone maintenance: a brief review. Journal of Substance Abuse Treatment 2010, 38(2):191-199. 10.1016/j.jsat.2009.10.001.
29. Richter K.P., Ahluwalia H.K., Mosier M.C., Nazir N., Ahluwalia J.S. A population-based study of cigarette smoking among illicit drug users in the United States. Addiction 2002, 97(7):861-869. (doi: 162 [pii]).
30. Richter K.P., Gibson C.A., Ahluwalia J.S., Schmelzle K.H. Tobacco use and quit attempts among methadone maintenance clients. American Journal of Public Health 2001, 91(2):296-299.
31. Robert Wood Johnson Foundation Health care's blind side: The overlooked connection between social needs and good health 2011, (Princeton, NJ).
32. Rounsaville B.J., Weissman M.M., Crits-Christoph K., Wilber C., Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Archives of General Psychiatry 1982, 39(2):151-156.
33. Senn T.E., Carey M.P., Vanable P.A. The intersection of violence, substance use, depression, and STDs: Testing of a syndemic pattern among patients attending an urban STD clinic. Journal of the National Medical Association 2010, 102(7):614-620.
34. Singer M., Clair S. Syndemics and public health: Reconceptualizing disease in bio-social context. Medical Anthropology Quarterly 2003, 17(4):423-441.
35. Stein M. Medical consequences of substance abuse. The Psychiatric Clinics of North America 1999, 22(2):351-370.
36. Stein M.D., Caviness C.M., Kurth M.E., Audet D., Olson J., Anderson B.J. Varenicline for smoking cessation among methadone-maintained smokers: A randomized clinical trial. Drug and Alcohol Dependence 2013, 133(2):486-493. 10.1016/j.drugalcdep.2013.07.005.
37. Stein M.D., Sobota M. Injection drug users: Hospital care and charges. Drug and Alcohol Dependence 2001, 64(1):117-120. (doi: S0376-8716(00)00235-0 [pii]).
38. Stein M.D., Weinstock M.C., Herman D.S., Anderson B.J., Anthony J.L., Niaura R. A smoking cessation intervention for the methadone-maintained. Addiction 2006, 101(4):599-607. 10.1111/j.1360-0443.2006.01406.x.
39. Substance Abuse and Mental Health Services Administration The DASIS Report: Admissions for detoxification, 2001 2004, Office of Applied Studies, Rockville, MD.
40. Williams C.T., Latkin C.A. Neighborhood socioeconomic status, personal network attributes, and use of heroin and cocaine. American Journal of Preventive Medicine 2007, 32(6 Suppl):S203-S210. 10.1016/j.amepre.2007.02.006.
41. Wu L.T., Woody G.E., Yang C., Blazer D.G. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine 2011, 5(1):28-35. 10.1097/ADM.0b013e3181e0364e.